Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors
US11981681B2 · kind B2 · utility
1Cited by
25References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 8, 2022 |
| Grant date | May 14, 2024 |
| Priority date | — |
| Expiry date | Jun 8, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4545
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel substituted azetidine dihydrothienopyridines with phosphodiesterase inhibitory activity, and to their use in therapy, and to pharmaceutical compositions comprising the compounds and to methods of treating diseases with the compounds (I)
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.